Dr Yulia Michailov presented interim clinical outcome results from QART MEDICAL’s multi-center clinical study
Dr Yulia Michailov, head of the IVF lab at Barzilay Medical Center, presented interim clinical outcome results from QART MEDICAL’s multi-center clinical study, at the Israel Fertility Association’s 2024 conference in Tel-Aviv, Israel
Raanana, Israel. June 3rd, 2024
QART Medical is honored to have the company’s interim clinical results presented at the Israel Fertility Association’s 66th annual conference.
The poster, titled “Preliminary Clinical Outcome Using the Q300™ Device in a Reproductive Laboratory Environment”, was one of 19 featured posters at this year’s conference. The poster summarizes the preliminary interim results from QART’s on-going, multi-center clinical study at Barzilai Medical Center in Ashkelon, Israel.
The study is meant to provide an understanding of the early clinical impact of the Q300™ in the IVF laboratory. The initial data suggests favorable outcomes, with further research necessary to identify the patient subgroups that can derive the greatest benefit from this system. The preliminary results focus on 14 couples attempting to achieve pregnancy. A copy of the poster can be found here: QART Medical Poster
The Israel Fertility Association (AYALA) conference, held yearly in Tel Aviv, brings together the country’s leading fertility experts with a focus on new technologies, techniques, and procedures.